MoneyWorks4Me

Earum Pharmaceuticals informs about disclosure

07 Jul 2023 Evaluate

Earum Pharmaceuticals has informed that the exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nimit Jayendrabhai Shah.

The above information is a part of company’s filings submitted to BSE.

Peers